Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T22655 | Target Info | |||
Target Name | Mucosal addressin cell adhesion molecule 1 (MADCAM1) | ||||
Synonyms |
hMAdCAM-1; MAdCAM-1; MADCAM1
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | MADCAM1 | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | C-X-C chemokine receptor type 2 (CXCR2) | Successful Target | ||||
UniProt ID | CXCR2_HUMAN | |||||
Gene Name | CXCR2 | |||||
Synonyms |
Interleukin-8 receptor B; IL8RB; IL-8R B; IL-8 receptor type 2; High affinity interleukin-8 receptor B; GRO/MGSA receptor; CXCR-2; CXC-R2; CDw128b; CD182
Click to Show/Hide
|
|||||
Representative Drug(s) | SCH-527123 | Drug Info | IC50 = 0.049 nM | [1] | ||
Co-Target Name | C-X-C chemokine receptor type 1 (CXCR1) | Successful Target | ||||
UniProt ID | CXCR1_HUMAN | |||||
Gene Name | CXCR1 | |||||
Synonyms |
Interleukin-8 receptor A; IL8RA; IL-8R A; IL-8 receptor type 1; High affinity interleukin-8 receptor A; CXCR-1; CXC-R1; CMKAR1; CDw128a; CD181
Click to Show/Hide
|
|||||
Representative Drug(s) | SCH-527123 | Drug Info | IC50 = 3.9 nM | [1] | ||
Co-Target Name | Interleukin 8 receptor (IL8R) | Literature-reported Target | ||||
UniProt ID | CXCR1_HUMAN; CXCR2_HUMAN | |||||
Gene Name | CXCR1; CXCR2 | |||||
Synonyms |
IL8R; IL-8R; IL-8 receptor; High affinity interleukin-8 receptor; CXCR; CXC-R; CDw128
Click to Show/Hide
|
|||||
Representative Drug(s) | SCH-527123 | Drug Info | IC50 = 16 nM | [2] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Chemokine receptor antagonists. J Med Chem. 2012 Nov 26;55(22):9363-92. | ||||
REF 2 | Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist. J Med Chem. 2006 Dec 28;49(26):7603-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.